Market Cap
$1.8B
NVAX
NOVAVAX INC
$10.35 ▼ -2.31%
Prev close $10.60Market cap$1.8B
12-mo target$14.00 (+35.2%)
High Impact Filing (8/10)25 New Institutional Positions25 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on NVAX right now — valuation, ownership and activity at a glance.
Cap Size
Small Cap
Inst. Holders
50 funds
Inst. Value
$880.5M
Inst. Activity
25 buys / 25 sells
Social Sentiment
56° Neutral
SEC Reports
4
Price chart 30d +0.3%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 23, 2026 short_volume
Aug 6, 2026 SEC Short Volume: NVAX — 58.7% short (1.5M / 2.6M)
Short: 1,499,305 | Exempt: 13,643 | TRF Vol: 2,554,203 | Short Ratio: 58.7% | Off-exchange volume (d
Novavax reported Q2 2026 total revenue of $57M, a 76% decline YoY from $239M, driven by the absence of a $175M BLA miles
8-K — Impact 5/10
Jun 30, 2026 Inst.
STATE STREET CORP — ADD
11,740,550 shares ($110.6M)
Jun 30, 2026 Inst.
D. E. Shaw & — TRIM
5,650,905 shares ($53.2M)
Jun 20, 2026 Insider
Alton Gregg H acquired via exercise 18,880 shares
Director
Jun 20, 2026 Insider
MOTT DAVID M acquired via exercise 18,880 shares
Director
Jun 20, 2026 Insider
May 6, 2026 SEC MCGLYNN MARGARET G acquired via exercise 18,880 shares
Director
Novavax reported Q1 2026 total revenue of $140M, down 79% YoY from $667M, which included $603M in non-cash APA close-out
8-K — Impact 4/10
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Jun 11, 2026 | BTIG | REITERATE | Buy | 53% |
| May 6, 2026 | TD Cowen | MAINTAIN | Hold | 56% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 4 | 6 | 2 | 2 | 1 | 67% | |
| Aug 1, 2026 | 4 | 6 | 2 | 2 | 1 | 67% | |
| Jul 1, 2026 | 4 | 6 | 2 | 2 | 1 | 67% | |
| Jun 1, 2026 | 4 | 6 | 2 | 2 | 1 | 67% | |
| May 1, 2026 | 4 | 6 | 2 | 2 | 1 | 67% | |
| Apr 1, 2026 | 4 | 6 | 2 | 2 | 1 | 67% | |
| Mar 1, 2026 | 4 | 6 | 2 | 2 | 1 | 67% | |
| Feb 1, 2026 | 4 | 6 | 2 | 2 | 1 | 67% |
Price targets
Where 9 covering analysts think NVAX trades over the next 12 months.
$14.00 +35.2% upside Strong Buy
Current$10.36 Low$7.00 Median$16.02 High$25.00 9 analysts
$7.00$25.00
Analyst rating Buy· 2.3/5 as of Oct 2, 2026
Social media sentiment mood -33.3%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
56°
Neutral
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
4 SEC filing reports analyzed · 1 bullish, 0 bearish, 0 mixed, 3 neutral · avg impact 4.8/10.
NEUTRAL8-K5/10
Novavax reported Q2 2026 total revenue of $57M, a 76% decline YoY from $239M, driven by the absence
Aug 6, 2026
NEUTRAL8-K4/10
Novavax reported Q1 2026 total revenue of $140M, down 79% YoY from $667M, which included $603M in no
May 6, 2026
NEUTRALDEFA14A2/10
Novavax has filed definitive additional proxy materials, indicating an active shareholder vote or co
Apr 27, 2026
BULLISH8-K8/10
Novavax reported strong financial results for Q4 and full year 2025, with revenue up 67% YoY to $147
Feb 26, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 23, 2026
short_volume
Short Volume: NVAX — 58.7% short (1.5M / 2.6M)
Short: 1,499,305 | Exempt: 13,643 | TRF Vol: 2,554,203 | Short Ratio: 58.7% | Off-exchange volume (dark pool + OTC)
Sep 16, 2026
short_volume
Short Volume: NVAX — 59.2% short (0.6M / 1.0M)
Short: 609,641 | Exempt: 311 | TRF Vol: 1,029,208 | Short Ratio: 59.2% | Off-exchange volume (dark pool + OTC)
Sep 15, 2026
short_volume
Short Volume: NVAX — 57.6% short (1.0M / 1.7M)
Short: 981,118 | Exempt: 3,400 | TRF Vol: 1,702,958 | Short Ratio: 57.6% | Off-exchange volume (dark pool + OTC)
Sep 10, 2026
short_volume
Short Volume: NVAX — 58.8% short (1.5M / 2.6M)
Short: 1,528,391 | Exempt: 3,850 | TRF Vol: 2,598,522 | Short Ratio: 58.8% | Off-exchange volume (dark pool + OTC)
Sep 2, 2026
other
Novavax to Participate in September Investor Conferences
GAITHERSBURG, Md., Sept. 2, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that company management will participate in the followin
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-0.18 | $-0.47–$0.50 | 86.0% | +0.0% | — | $0.1B | 8 |
| Next Q | $-0.11 | $-0.47–$0.31 | -200.3% | +0.0% | — | $0.1B | 8 |
| Current FY | $-0.63 | $-1.32–$0.48 | -124.2% | +0.0% | 0↑ 2↓ | $0.4B | 9 |
| Next FY | $-0.22 | $-0.85–$0.67 | 64.1% | +0.0% | 1↑ 0↓ | $0.3B | 9 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.176 | — |
| 7d ago | $-0.176 | — |
| 30d ago | $-0.176 | — |
| 60d ago | $-0.022 | -0.154 |
| 90d ago | $-0.022 | -0.154 |
Institutional ownership
Which big funds own NVAX (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $880.5M total value (93,475,131 shares) as of 2026-Q2. Top holders: BlackRock,, STATE, VANGUARD.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 13,946,881 | $131.4M | 14.9% | — |
| STATE STREET CORP | 11,740,550 | $110.6M | 12.6% | ADD +30.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7,607,996 | $71.7M | 8.1% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 7,257,449 | $68.4M | 7.8% | — |
| D. E. Shaw & Co., Inc. | 5,650,905 | $53.2M | 6.0% | TRIM -26.7% |
| GEODE CAPITAL MANAGEMENT, LLC | 4,207,370 | $39.6M | 4.5% | — |
| TWO SIGMA INVESTMENTS, LP | 4,091,043 | $38.5M | 4.4% | — |
| COATUE MANAGEMENT LLC | 3,836,986 | $36.1M | 4.1% | — |
| BANK OF AMERICA CORP /DE/ | 3,416,235 | $32.2M | 3.7% | TRIM -48.5% |
| GOLDMAN SACHS GROUP INC | 3,007,756 | $28.3M | 3.2% | DOUBLED +113.4% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| STATE STREET CORP | ADD | 8,970,518 | 11,740,550 | +30.9% | $110.6M |
| D. E. Shaw & Co., Inc. | TRIM | 7,709,858 | 5,650,905 | -26.7% | $53.2M |
| BANK OF AMERICA CORP /DE/ | TRIM | 6,637,213 | 3,416,235 | -48.5% | $32.2M |
| GOLDMAN SACHS GROUP INC | DOUBLED | 1,409,446 | 3,007,756 | +113.4% | $28.3M |
| UBS Group AG | TRIM | 4,477,701 | 1,869,659 | -58.2% | $17.6M |
| MILLENNIUM MANAGEMENT LLC | TRIM | 3,852,545 | 1,768,163 | -54.1% | $16.7M |
| CITADEL ADVISORS LLC | ADD | 1,123,746 | 1,695,313 | +50.9% | $16.0M |
| JUPITER ASSET MANAGEMENT LTD | NEW | — | 1,070,232 | — | $10.1M |
| FEDERATED HERMES, INC. | DOUBLED | 4,753 | 703,006 | +14690.8% | $6.6M |
| Point72 Asset Management, L.P. | TRIM | 1,518,211 | 664,286 | -56.2% | $6.3M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
14 insiders, 50 transactions. Net $0.00 — $0.00 bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 20, 2026 | Alton Gregg H | Director | EXERCISE | 18,880 | — | — |
| Jun 20, 2026 | MOTT DAVID M | Director | EXERCISE | 18,880 | — | — |
| Jun 20, 2026 | MCGLYNN MARGARET G | Director | EXERCISE | 18,880 | — | — |
| Jun 20, 2026 | DOUGLAS RICHARD | Director | EXERCISE | 18,880 | — | — |
| Jun 20, 2026 | King Rachel K. | Director | EXERCISE | 18,880 | — | — |
| Jun 20, 2026 | Rodgers Richard J | Director | EXERCISE | 18,880 | — | — |
| Jun 18, 2026 | Newton Charles W. | Director | AWARD | 21,270 | — | — |
| Jun 18, 2026 | Shiver John W. | Director | AWARD | 21,270 | — | — |
| Jun 18, 2026 | Shiver John W. | Director | AWARD | 14,180 | — | — |
| Jun 18, 2026 | Newton Charles W. | Director | AWARD | 14,180 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for NVAX.
Shares short
49,875,210
Settlement Sep 15, 2026
Change vs prior
+2.2%
Semi-monthly cycle
Days to cover
9.3
At avg daily volume
Of shares outstanding
≈30.2%
Estimate — not % of float
All NVAX filing & press-release reports (4)
- 8-K reportAug 6, 2026
- 8-K reportMay 6, 2026
- DEFA14A reportApr 27, 2026
- 8-K reportFeb 26, 2026